Takeda Pharmaceutical Co. Ltd. reported its financial results for the fiscal year ending March 31, 2024, showing revenues of ¥4,263.8 billion, up 5.9% from the previous year, despite a 54.5% drop in net profit to ¥144.2 billion. This filing, made on May 9, 2024, serves as a summary of financial statements.